ClinicalTrials.Veeva

Menu

Does DNA Sperm Fragmentation Affects Embryo Morphokinetic? (MACs-ESD)

I

IVI Madrid

Status

Terminated

Conditions

Cleavage Times
Blastocyst Time
Pronuclear Appearance
Embryo Compaction
Pronuclear Fading

Treatments

Other: MACS

Study type

Interventional

Funder types

Other

Identifiers

NCT02214537
MADDA12201301

Details and patient eligibility

About

The embryokinetics may be a new prognostic factor for choosing the human embryos with the highest implantation potential. In order to identify the factors that may affect the rate of embryo cleavage, there are many studies about morphokinetics and culture medium, oxygen tension, oocyte quality or type of medication used for ovarian stimulation. However there are no published data with respect to the influence of sperm DNA fragmentation in the embryo kinetic.

Enrollment

60 patients

Sex

All

Ages

36 to 38 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients 36 to 38 years
  • Fresh sample semen
  • Minimum 6 oocytes
  • Semen sample with at least 5 million/ml and at least 30% of progressive motile sperm.

Exclusion criteria

  • Patients younger than 36 or older than 38 years old
  • Frozen semen sample
  • Less tan 6 oocytes.
  • Semen samples with less than 5 million / ml or less than 30% of motile sperm.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

MACS
Experimental group
Description:
Patients with MACS Selection
Treatment:
Other: MACS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems